gadolinium has been researched along with Acoustic Neurinoma, Bilateral in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conibear, J; Eminowicz, GK; Plowman, PN; Raman, R | 1 |
| Kanno, H; Kitamura, H; Yamamoto, I; Yoshida, M | 1 |
| Baser, ME; Brackmann, DE; Briggs, RJ; Hitselberger, WE | 1 |
| Haltia, MJ; Jääskeläinen, JE; Kinnunen, JJ; Sainio, MA; Seppälä, MT; Setälä, KH | 1 |
| Baser, ME; Makariou, EV; Parry, DM | 1 |
| Baser, ME; Feigen, UM; Friedman, JM; Kluwe, L; Mautner, VF; Thakkar, SD | 1 |
1 review(s) available for gadolinium and Acoustic Neurinoma, Bilateral
| Article | Year |
|---|---|
Comprehensive management of bilateral acoustic neuromas. Current perspectives.
Topics: Adolescent; Adult; Audiometry; Child; Cochlear Implants; Comprehensive Health Care; Craniotomy; Female; Gadolinium; Genes, Neurofibromatosis 2; Humans; Incidence; Magnetic Resonance Imaging; Male; Mass Screening; Neurofibromatosis 2; Patient Education as Topic; Pedigree; Tomography, X-Ray Computed | 1994 |
5 other study(ies) available for gadolinium and Acoustic Neurinoma, Bilateral
| Article | Year |
|---|---|
Bevacizumab treatment for vestibular schwannomas in neurofibromatosis type two: report of two cases, including responses after prior gamma knife and vascular endothelial growth factor inhibition therapy.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Contrast Media; Female; Gadolinium; Hearing Loss, Unilateral; Humans; Magnetic Resonance Imaging; Male; Neurofibromatosis 2; Neuroma, Acoustic; Radiosurgery; Remission Induction; Treatment Outcome; Vascular Endothelial Growth Factors | 2012 |
Meningioma showing VHL gene inactivation in a patient with von Hippel-Lindau disease.
Topics: Aged; Carcinoma, Renal Cell; Cerebellar Neoplasms; Chromosomes, Human, Pair 3; Dementia; Disease Progression; DNA Mutational Analysis; Fatal Outcome; Gadolinium; Gait Disorders, Neurologic; Germ-Line Mutation; Hemangioblastoma; Humans; Ligases; Loss of Heterozygosity; Magnetic Resonance Imaging; Male; Meningioma; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Neurofibromatosis 2; Speech Disorders; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; von Hippel-Lindau Disease; Von Hippel-Lindau Tumor Suppressor Protein | 2003 |
Multiple schwannomas: schwannomatosis or neurofibromatosis type 2?
Topics: Adult; Child; Contrast Media; Diagnosis, Differential; Female; Follow-Up Studies; Gadolinium; Genes, Neurofibromatosis 2; Germ-Line Mutation; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Neoplasms, Second Primary; Neurilemmoma; Neurofibromatosis 2; Peripheral Nervous System Neoplasms; Spinal Cord Neoplasms; Treatment Outcome | 1998 |
Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2.
Topics: Adolescent; Adult; Age Factors; Aged; Blotting, Southern; Brain; Child; Child, Preschool; Female; Gadolinium; Genes, Neurofibromatosis 2; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Neurofibromatosis 2; Neuroma, Acoustic; Polymorphism, Single-Stranded Conformational; Predictive Value of Tests; Retrospective Studies; Severity of Illness Index | 2002 |
Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study.
Topics: Adolescent; Adult; Age Factors; Brain; Child; DNA Mutational Analysis; Female; Follow-Up Studies; Gadolinium; Genes, Neurofibromatosis 2; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mutation; Neurofibromatosis 2; Neuroma, Acoustic; Severity of Illness Index; Spine; Time Factors | 2002 |